Contact PT-141 Legit.

Editorial correspondence

PT-141 Legit accepts editorial correspondence on the published digest — corrections to citations, requests to add a published primary source we may have missed, notes on the editorial framing of a claim. We read every message and reply when a substantive editorial response is warranted.

We do not, however, provide individualized advice. We cannot answer:

• Whether PT-141 is appropriate for you or any individual
• What dose to take, what schedule to use, or how to self-administer
• Where to purchase any form of the compound
• How to evaluate any specific research-peptide vendor or pharmacy
• Whether a particular adverse event is concerning

Those questions belong with a licensed clinician who can examine the patient, review the medical history, and prescribe within the scope of an established clinical relationship. Nothing on this site substitutes for that relationship.

Editorial note

All correspondence is read by the editorial team only. Citations and content updates are batched and published on a non-fixed schedule. We do not maintain a public comment section.